Table 4.
CYP Metabolizer | Drug with a Known TdP Risk | Type X Interactions When Combined with (High Risk of QT Prolongation) |
---|---|---|
CYP3A4 | Amiodarone | Voriconazol |
Indinavir | ||
Ritonavir | ||
Saquinavir | ||
Clarithromycin | ||
Disopyramide | Itraconazol | |
Clarithromycin | ||
Ketoconazol (systemic) | ||
Saquinavir | ||
Telithromycin | ||
Dofetilide | Clarithromycin | |
Itraconazole | ||
Ketoconazole | ||
Dronedarone | Clarithromycin | |
Ceritinib | ||
Indinavir | ||
Itraconazole | ||
Nefazodone | ||
Ritonavir | ||
Saquinavir | ||
Telithromycin | ||
Voriconazole | ||
Ibutilide | Clarithromycin | |
Quinidine | Clarithromycin | |
Itraconazol | ||
Ketoconazol | ||
Ritonavir | ||
Saquinavir | ||
Voriconazole | ||
Azithromycin | Certinib | |
Clarithromycin | ||
Saquinavir | ||
Voriconazole | ||
Clarithromycin | Saquinavir | |
Erythromycin | Saquinavir | |
Cloroquine | Ceritinib | |
Clarithromycin | ||
Saquinavir | ||
Voriconazole | ||
Chlorpromazine | Certinib Saquinavir |
|
Voriconazol | ||
Clarithromycin | ||
Haloperidol | Saquinavir | |
Levomepromazine | Ritonavir Saquinavir |
|
Escitalopram | - | |
Ondansetron | - | |
Cisapride | Ceritinib | |
Clarithromycin | ||
Indinavir | ||
Itraconazole | ||
Ketoconazole | ||
Nefazodone | ||
2D6 | Flecainide | |
Ibutilide | Quinidine | |
Procainamide | Quinidine | |
Chloroquine | - | |
Hydroxychloroquine | - | |
Chlorpromazine | - | |
Haloperidol | - | |
2C19 | Citalopram | - |
Escitalopram | - | |
Chlorpromazine | - |
The drugs metabolized by a given CYP were crossed with the drugs known inhibit the respective CYP (See Supplementary Table S1) taken from [91]. Known TdP risk drugs were taken from CredibleMeds® list of known risk of TdP drugs [24]. Drug interactions were analyzed for the potential drug interactions using Lexi-Interact™ Online available on the website www.uptodate.com (accessed on 10 June 2021) [89].